Healthcare Triangle, Inc. Secures Continued Nasdaq Listing Amid Compliance Efforts
Healthcare Triangle, Inc. has been granted continued listing on Nasdaq after addressing compliance issues, marking a significant step towards stabilizing its market position and ensuring investor confidence.
Healthcare Triangle, Inc. (Nasdaq: HCTI) has successfully secured the Nasdaq Hearings Panel's approval for the continued listing of its securities, following a review of compliance with Nasdaq's shareholders' equity rule. The decision allows the company to maintain its presence on the Nasdaq, contingent upon meeting specific conditions aimed at ensuring long-term compliance with the Bid Price Rule.
The Panel's conditions include the execution of a reverse stock split by August 8, 2025, and the demonstration of compliance with the Bid Price Rule by maintaining a $1 closing bid price for at least twenty consecutive trading days by September 5, 2025. Additionally, a Discretionary Panel Monitor will oversee the company's compliance for a year following the determination.
Dave Rosa, Chairman of the Board of Directors at HCTI, expressed gratitude for the Panel's decision, emphasizing the company's commitment to advancing its mission through strategic growth and the empowerment of healthcare organizations via innovative technologies. Healthcare Triangle, Inc. remains focused on enhancing shareholder value and will continue to provide updates to its stakeholders.